2J7L image
Deposition Date 2006-10-12
Release Date 2006-11-01
Last Version Date 2024-11-06
Entry Detail
PDB ID:
2J7L
Title:
E. coli P Pilus chaperone PapD in complex with a pilus biogenesis inhibitor, pilicide 2c
Biological Source:
Source Organism:
ESCHERICHIA COLI (Taxon ID: 562)
Host Organism:
Method Details:
Experimental Method:
Resolution:
2.60 Å
R-Value Free:
0.27
R-Value Work:
0.23
R-Value Observed:
0.23
Space Group:
P 63 2 2
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:CHAPERONE PROTEIN PAPD
Gene (Uniprot):papD
Chain IDs:A
Chain Length:218
Number of Molecules:1
Biological Source:ESCHERICHIA COLI
Ligand Molecules
Primary Citation
Rationally Designed Small Compounds Inhibit Pilus Biogenesis in Uropathogenic Bacteria.
Proc.Natl.Acad.Sci.USA 103 17897 ? (2006)
PMID: 17098869 DOI: 10.1073/PNAS.0606795103

Abstact

A chemical synthesis platform with broad applications and flexibility was rationally designed to inhibit biogenesis of adhesive pili assembled by the chaperone-usher pathway in Gram-negative pathogens. The activity of a family of bicyclic 2-pyridones, termed pilicides, was evaluated in two different pilus biogenesis systems in uropathogenic Escherichia coli. Hemagglutination mediated by either type 1 or P pili, adherence to bladder cells, and biofilm formation mediated by type 1 pili were all reduced by approximately 90% in laboratory and clinical E. coli strains. The structure of the pilicide bound to the P pilus chaperone PapD revealed that the pilicide bound to the surface of the chaperone known to interact with the usher, the outer-membrane assembly platform where pili are assembled. Point mutations in the pilicide-binding site dramatically reduced pilus formation but did not block the ability of PapD to bind subunits and mediate their folding. Surface plasmon resonance experiments confirmed that the pilicide interfered with the binding of chaperone-subunit complexes to the usher. These pilicides thus target key virulence factors in pathogenic bacteria and represent a promising proof of concept for developing drugs that function by targeting virulence factors.

Legend

Protein

Chemical

Disease

Primary Citation of related structures